9:35am ET
Health and Healthcare
8 Major Biopharma Events Coming Later in 2016 and in 2017
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
Companies
/Healthcare
Biocryst Pharmaceuticals Inc
$9.70
▼ $0.12 (−1.22%) today
Markets closed · 11:18pm ET
BCRX Coverage
Page 310:15am ET
Health and Healthcare
4 BioPharma Movers That Cannot Be Ignored
These biotech companies 24/7 Wall St. has picked stood out from the rest with big moves over the course of last week.
11:05am ET
Health and Healthcare
Is BioCryst Reaching Crush Depth?
BioCryst Pharmaceuticals shares were crushed after it announced results from OPuS-2 for the treatment of hereditary angioedema attacks.
Jon C. Ogg 10:10am ET
Investing
Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End and More
For the third straight week, insider selling has been nonexistent, while the insider buyers have taken advantage of the market sell-off.
8:35am ET
Investing
Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start
Jefferies is out with its first group of growth stocks to buy this year, and the list has not only some timely picks, but companies that have been knocked to levels that…
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More
The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels, Lockheed Martin and Rite Aid.
10:16am ET
Health and Healthcare
4 Key FDA Decisions Expected By Year End
Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk…
Chris Lange 9:10am ET
Health and Healthcare
4 Key FDA Decisions Expected in November and December
24/7 Wall St. has collected several big FDA decisions coming up in the month of November.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More
Friday's top analyst upgrades, downgrades and initiations include AT&T, BioCryst Pharmaceuticals, Eli Lilly, Facebook, Flextronics, Gap and Tesla Motors.
4:11pm ET
Health and Healthcare
BioCryst Upgrade Almost Looks Misunderstood
The most recent analyst call by Merrill Lynch for BioCryst Pharmaceuticals may be very misunderstood for what it is.
Chris Lange 9:40am ET
Health and Healthcare
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight.
3:45pm ET
Health and Healthcare
Ebola Finances Coming Back in the News
Within the past week, two Ebola-related companies are showing renewed optimism for their positions, whether it is securing a contract or raising capital.
Chris Lange 2:10pm ET
Health and Healthcare
5 Critical Biotech Drug Dates and Events for December
At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks.
2:10pm ET
Health and Healthcare
Ebola Stock Short Interest Surprise
Some Ebola-related stocks had been heavily shorted as they were considered by many investors as the next would-be stock bubble from a major news event.
3:30pm ET
Health and Healthcare
New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)
ThinkstockJust when you thought the Ebola virus outbreak risk was dwindling down… Fresh headlines from Dow Jones and the New York post have put the markets on Ebola watch all over again.…